GATA2 gene mutation can indicate risk of blood cancers

09/5/2011 | Sydney Morning Herald (Australia), The

Australian researchers have found that mutations in the GATA2 gene could indicate that a person is more vulnerable to developing blood cancers such as myelodysplastic syndrome and acute myeloid leukemia. The gene influences the functions of genes involved in the production of white blood cells. A clinical trial is being undertaken in the U.S. to explore treatment options.

View Full Article in:

Sydney Morning Herald (Australia), The

Published in Brief:

SmartBrief Job Listings for Health Care

Job Title Company Location
Counsel – Regulatory Affairs
RAI Services Company
Winston Salem, NC
Director of Program Development
AdvaMed
Washington DC, DC
Director of System QA
LifeWatch Services, Inc.
Rosemont, IL
Director of Business Development and Membership
AdvaMed
Washington DC, DC
Director, Corporate Counsel
Regeneron
Tarrytown, NY